- Home
- NAGE vs REAX Comparison
NAGE vs REAX Comparison
Compare NAGE & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- REAX
- Stock Information
- Founded
- NAGE 1999
- REAX 2018
- Country
- NAGE United States
- REAX United States
- Employees
- NAGE N/A
- REAX N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- REAX
- Sector
- NAGE Health Care
- REAX
- Exchange
- NAGE Nasdaq
- REAX Nasdaq
- Market Cap
- NAGE 861.0M
- REAX 849.5M
- IPO Year
- NAGE N/A
- REAX N/A
- Fundamental
- Price
- NAGE $9.04
- REAX $3.88
- Analyst Decision
- NAGE Strong Buy
- REAX Strong Buy
- Analyst Count
- NAGE 3
- REAX 3
- Target Price
- NAGE $16.67
- REAX $6.33
- AVG Volume (30 Days)
- NAGE 1.2M
- REAX 855.7K
- Earning Date
- NAGE 08-06-2025
- REAX 08-07-2025
- Dividend Yield
- NAGE N/A
- REAX N/A
- EPS Growth
- NAGE N/A
- REAX N/A
- EPS
- NAGE 0.18
- REAX N/A
- Revenue
- NAGE $107,925,000.00
- REAX $1,417,877,000.00
- Revenue This Year
- NAGE $26.44
- REAX $44.55
- Revenue Next Year
- NAGE $20.06
- REAX $16.68
- P/E Ratio
- NAGE $50.51
- REAX N/A
- Revenue Growth
- NAGE 29.77
- REAX 81.30
- 52 Week Low
- NAGE $2.53
- REAX $3.80
- 52 Week High
- NAGE $14.69
- REAX $6.75
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- REAX 39.26
- Support Level
- NAGE N/A
- REAX $3.81
- Resistance Level
- NAGE N/A
- REAX $4.17
- Average True Range (ATR)
- NAGE 0.00
- REAX 0.15
- MACD
- NAGE 0.00
- REAX -0.02
- Stochastic Oscillator
- NAGE 0.00
- REAX 11.67
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.